Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Artificial cells, blood substitutes, and immobilization biotechnology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/10731199709118893PMID 9083622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.

  1996cited by this paper
• S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control

  1996cited by this paper
• Artificial cells with emphasis on bioencapsulation in biotechnology.

  1995cited by this paper
• Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro.

  1995cited by this paper
• Stabilized hemoglobin vesicles.

  1994cited by this paper
• A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study.

  1994cited by this paper
• A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: A prospective, randomized, controlled study

  1994cited by this paper
• Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.

  1994cited by this paper
• Assessment of blood substitutes: II. In-vitro complement activation of human plasma and blood for safety studies in research, development, industrial production and preclinical analysis.

  1994cited by this paper
• Encapsulated hemoglobin: current issues and future goals.

  1994cited by this paper
• Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin.

  1994cited by this paper
• Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free radicals and prevents methemoglobin formation and iron release.

  1993cited by this paper
• PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model.

  1992cited by this paper
• Hemoglobin tetramers stabilized with polyaspirins.

  1992cited by this paper
• Immunogenicity of diaspirin cross-linked human hemoglobin solutions.

  1992cited by this paper
• Relationship between chemical properties and biological properties of pyridoxalated hemoglobin-polyoxyethylene.

  1992cited by this paper
• The first recorded blood transfusions: 1656 to 1668

  1990cited by this paper
• Myoglobin and haemoglobin: role of distal residues in reactions with haem ligands.

  1989cited by this paper
• Conjugated Hemoglobin: Rightshifted Dextran-Hemoglobin as Blood Substitute

  1988cited by this paper
• Rightshifted dextran-hemoglobin as blood substitute.

  1988cited by this paper
• "Attempts to find a method to prepare artificial hemoglobin corpuscles".

  1988cited by this paper
• Liposome-encapsulated hemoglobin: oxygen binding properties and respiratory function.

  1988cited by this paper
• Hemoglobin solution--from tetramer to polymer.

  1984cited by this paper
• Blood exchange with pyridoxalated and polymerized hemoglobin solution.

  1982cited by this paper
• Synthetic erythrocytes from lipid encapsulated hemoglobin.

  1980cited by this paper
• The development of haemoglobin preparations for various indications.

  1980cited by this paper
• Diaspirins that cross-link beta chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate.

  1979cited by this paper
• An improved perfluorodecalin emulsion.

  1978cited by this paper
• Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals.

  1976cited by this paper
• Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals.

  1976cited by this paper
• Hemoglobin covalently bridged across the polyphoshate binding site.

  1975cited by this paper
• Polymerization of proteins with glutaraldehyde. Soluble molecular-weight markers.

  1973cited by this paper
• Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde.

  1971cited by this paper
• THE RENAL HANDLING OF HEMOGLOBIN

  1969cited by this paper
• The renal handling of hemoglobin.

  1968cited by this paper
• Semipermeable Microcapsules containing Catalase for Enzyme Replacement in Acatalasaemic Mice

  1968cited by this paper
• Erythrocyte Substitute for Perfusion of Brain

  1967cited by this paper
• Semipermeable aqueous microcapsules ("artificial cells"): with emphasis on experiments in an extracorporeal shunt system.

  1966cited by this paper
• Semipermeable aqueous microcapsules. I. Preparation and properties.

  1966cited by this paper
• Semipermeable aqueous microcapsules ("artificial cells"): with emphasis on experiments in an extracorporeal shunt system.

  1966cited by this paper
• Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure

  1966cited by this paper
• Semipermeable Microcapsules

  1964cited by this paper

• Preparation and biomedical applications of artificial cells

  2023cites this paper
• Preparation, characterisation, and controlled release of sex pheromone-loaded MPEG-PCL diblock copolymer micelles for Spodoptera litura (Lepidoptera: Noctuidae)

  2018cites this paper
• Polypeptide-based artificial erythrocytes conjugated with near infrared photosensitizers for imaging-guided photodynamic therapy

  2018cites this paper
• Analysis of Dimeric αβ Subunit Exchange between PEGylated and Native Hemoglobins (α2β2 Tetramer) in an Equilibrated State by Intramolecular ββ-Cross-Linking.

  2018cites this paper
• A novel bio-nanocomposite based on hemoglobin and carboxyl graphene for enhancing the ability of carrying oxygen

  2016cites this paper
• Hemoglobin‐Based Nanoarchitectonic Assemblies as Oxygen Carriers

  2016cites this paper
• Deformation of an elastic capsule in a uniform electric field

  2014cites this paper
• Inhibition of methemoglobin formation in aqueous solutions under aerobic conditions by the addition of amino acids.

  2014cites this paper
• Globin engineering studies: optimizing the designs of circularly permuted myoglobin and single-chain hemoglobin

  2013cites this paper
• Chapter II.5.4 – Artificial Cells

  2013cites this paper
• Oxygen Delivery via Allosteric Effectors of Hemoglobin and Blood Substitutes

  2010cites this paper
• Current views about reperfusion injury mechanism in infusion therapy of shock and methods its prevention

  2009cites this paper
• The effects of decreasing low-molecular weight hemoglobin components of hemoglobin-based oxygen carriers in swine with hemorrhagic shock.

  2008cites this paper
• Massive Transfusion and Control of Hemorrhage in the Trauma Patient

  2008cites this paper
• Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers.

  2007cites this paper
• 18 – Artificial cells in enzyme therapy with emphasis on tyrosinase for melanoma in mice

  2007cites this paper
• 12 – Artificial cells in medicine: with emphasis on blood substitutes

  2007cites this paper
• Influence of O(2)-carrying plasma hemoprotein "albumin-heme" on complement system and platelet activation in vitro and physiological responses to exchange transfusion.

  2007cites this paper
• Chapter 45 – Nanodimension Biodegradable Polymeric Membrane Artificial Red Blood Cells

  2006cites this paper
• Chapter 46 – Albumin-Heme: A Synthetic Heme-Based Oxygen Carrier

  2006cites this paper
• Artificial Cells for Blood Substitutes, Enzyme Therapy, Cell Therapy and Drug Delivery

  2005cites this paper
• Oxygen-Carrying Plasma Hemoprotein Including Synthetic Heme

  2005cites this paper
• Methods for Bioencapsulation of Enzymes and Cells

  2005cites this paper
• Hemolysate-filled polyethyleneimine and polyurea microcapsules as potential red blood cell substitutes: effect of aqueous monomer type on properties of the prepared microcapsules.

  2004cites this paper
• Exchange transfusion with entirely synthetic red-cell substitute albumin-heme into rats: physiological responses and blood biochemical tests.

  2004cites this paper
• Exchange transfusion with synthetic oxygen-carrying plasma protein "albumin-heme" into an acute anemia rat model after seventy-percent hemodilution.

  2004cites this paper
• Artificial cells for cell and organ replacements.

  2004cites this paper
• Artificial Cell Bioencapsulation in Macro, Micro, Nano, and Molecular Dimensions: Keynote Lecture

  2004influential citation
• Effects of Combined Oral Administration and Intravenous Injection on Maintaining Decreased Systemic Tyrosine Levels in Rats

  2004cites this paper
• THE DEVELOPMENT OF POLYHB-FG: A NOVEL BLOOD SUBSTITUTE WITH THE POTENTIAL TO SUPPORT COAGULATION

  2003cites this paper
• Resuscitation with a novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage.

  2003cites this paper
• Human serum albumin incorporating synthetic heme: red blood cell substitute without hypertension by nitric oxide scavenging.

  2003cites this paper
• Molecular engineering of proteins with predefined function. Part I: Design of a hemoglobin-based oxygen carrier.

  2003cites this paper
• Artificial Cells for Replacement of Metabolic Organ Functions

  2003influential citation
• The Preparation and Characterization of Monomethoxypoly(ethylene glycol)‐b‐poly‐DL‐lactide Microcapsules Containing Bovine Hemoglobin

  2003cites this paper
• Blood Cell Substitutes

  2002cites this paper
• RED BLOOD CELL SUBSTITUTES*

  2002cites this paper
• Hemoglobin-Based Artificial Oxygen Carriers (HBOC): Classification and Historical Overview

  2002cites this paper
• 74 – Blood Substitutes in Surgery

  2001cites this paper
• Oxygen therapeutics--current concepts.

  2001cites this paper
• Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms

  2001cites this paper
• Molecular engineering of a polymer of tetrameric hemoglobins

  2001cites this paper
• Comparison of the Effects of Different Antiviral Treatments on the Antioxidant Systems of Stroma-free Hemoglobin¶

  2001cites this paper
• Involvement of reactive oxygen species in hemoglobin oxidation and virus inactivation by 1,9-dimethylmethylene blue phototreatment.

  2001cites this paper
• The heme-globin and dimerization equilibria of recombinant human hemoglobins carrying site-specific beta chains mutations.

  2001cites this paper
• Hemoglobin-Based Oxygen Carriers, Blood Substitutes, and Their Relevance to High-Volume Blood Loss

  2001cites this paper
• Medidas farmacológicas de ahorro de sangre en cirugía

  2001cites this paper
• Reaction of nitric oxide with synthetic hemoprotein, human serum albumin incorporating tetraphenylporphinatoiron(II) derivatives.

  2001cites this paper
• Parenteral Drug Delivery

  2000cites this paper
• Autologe Plasmapherese: Wertvolles Gerinnungstherapeutikum oder teurer Volumenersatz?

  2000cites this paper
• Red blood cell substitutes.

  2000cites this paper
• Effects of hemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure.

  2000cites this paper
• Virus Photoinactivation in Stroma-free Hemoglobin with Methylene Blue or 1,9-dimethylmethylene Blue

  2000cites this paper
• [Hemoglobin solutions].

  2000cites this paper
• Virus Photoinactivation in Stroma‐free Hemoglobin with Methylene Blue or 1,9‐dimethylmethylene Blue

  2000cites this paper
• A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.

  1999cites this paper
• Formulation of defined media for carbon monoxide fermentation by Eubacterium limosum KIST612 and the growth characteristics of the bacterium.

  1999cites this paper
• Future prospects for artificial blood.

  1999cites this paper
• Modified haemoglobins and perfluorocarbons.

  1999cites this paper
• Reactions of Sperm Whale Myoglobin with Hydrogen Peroxide

  1999cites this paper
• O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin.

  1999cites this paper
• Perfluorinated blood substitutes and artificial oxygen carriers.

  1999cites this paper
• Microencapsulation of enzymes, cells, and genetically engineered microorganisms.

  1999cites this paper
• Mechanistic studies of the oxidation of pyridoxalated hemoglobin polyoxyethylene conjugate by nitrogen monoxide.

  1999cites this paper
• Modified hemoglobin blood substitutes: present status and future perspectives.

  1998cites this paper
• Chapter 13 – Polymeric Biodegradable Hemoglobin Nanocapsule as a New Red Blood Cell Substitute

  1998cites this paper
• Preparation of red blood cells containing exogenous hemoglobin.

  1998cites this paper
• Artificial cells with emphasis on cell encapsulation of genetically engineered cells.

  1998cites this paper
• Artificial oxygen carriers.

  1998cites this paper
• Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin

  1998cites this paper
• Pharmaceutical and therapeutic applications of artificial cells including microencapsulation.

  1998cites this paper
• Red blood cell substitutes

  1998cites this paper
• O-Raffinose Crosslinking Substantially Ameliorates the Vasoconstrictive and Nitric-Oxide-Inactivating Effects of Unmodified Human Hemoglobin in the Rat

  1997cites this paper
• Efficient chemical introduction of a disulfide cross-link and conjugation site into human hemoglobin at beta-lysine-82 utilizing a bifunctional aminoacyl phosphate.

  1997cites this paper
• Artificial Cells and Bioencapsulation in Bioartificial Organs a

  1997cites this paper
• Recent advances in the development of haemoglobin-based blood substitutes.

  1997cites this paper